The Marin County developer of treatments for rare diseases noted that its treatment for a form of rickets has been driving ...

The Danish firm’s patents for semaglutide, the active pharmaceutical ingredient in its star brands, will start expiring in ...

CCHR says the VA and DoD waste billions of dollars on treatments that contribute to high suicide rates, sudden deaths and ...

A 2021 Canadian study reported that 1,445 medicinal plant species are harvested for commercial products, 1,217 of which are ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

As Trump gears up to reenter the White House and bring RFK Jr. with him, Kennedy has signaled what exactly his role would look like.

McGurrin has helped lead innovative startups in the pharmaceutical space. But beyond his experience in the field, his training as a CFO/ COO and strategic executive has made him uniquely qualified to ...

As former President Donald Trump has clinched a second term with a victory, his health care priorities will differ somewhat from his first term, ...

ANI Pharmaceuticals ranks in the middle for consensus rating among its peers. It is at the bottom for revenue growth. In terms of gross profit, it is at the top among its peers. However, for return on ...

Deal-making has slowed in recent years, largely due to high interest rates, soaring company valuations and a tight regulatory environment.

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

One stock yields 6% today. Another has grown its dividend by 460% over the past decade. Both are blue chip bargains to buy ...